"Mount Sinai-Led Consortium Gets $6.5 Million For Precision Medicine Work" - Jonathan LaMantia
A consortium led by the Icahn Institute at Mount Sinai has received $6.5 million from the National Institutes of Health to conduct research on precision medicine. The award comes as the market for precision medicine, which uses factors including genes and lifestyle to individualize treatment, continues to expand. Work funded by the NIH grant will focus on building reusable computer models to advance the field. Jonathan Karr, PhD, assistant professor of genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai will lead the NIH-funded work out of Mount Sinai. Significant advances in precision medicine and bioengineering will require detailed knowledge of cells and other biological entities. However, building predictive and reusable computer models of these biological entities has been limited to date.
- Jonathan R. Karr, PhD, Assistant Professor, Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai
Additional coverage:
Integrated, Multi-“omic” Studies of Asthma Could Lead to Precision Treatment
Jul 02, 2019 View All Press Releases
Mount Sinai and IBM Researchers Uncover Key to Greater Efficacy in Cancer Treatment
Mar 21, 2019 View All Press ReleasesNeurodegenerative Diseases Identified Using Artificial Intelligence
Mar 04, 2019 View All Press Releases